Clinical Trials Browser

OTHER × Pancreatic Neoplasms × pidilizumab × Clear all

NCT01313416 2019-07-10

Gemcitabine and CT-011 for Resected Pancreatic Cancer

Phase 2 Terminated

2 enrolled 5 charts

Gastrointestinal

Pancreatic Neoplasms